Overview

Given the fast growth of Pharmaceutical market in the last couple of years, Iraq seems to be in good fortune to offer good investment opportunities for foreign medical device and medicinal product manufacturers. The State Company for Marketing Drugs and Medical Appliances (KIMADIA) under the surveillance of Ministry of Health regulates marketing authorization, registration, Regulatory inspection, import control, licensing and all other Regulatory procedures. Effective navigation through the market requirements depends on ones understanding of regional market requirements, which otherwise may pose compliance challenges.

As a specialized Regulatory partner with an exclusive regional hub for MENA region, Freyr assists manufacturers overcome the Iraqi Regulatory procedural challenges pertaining to registrations, licensing and product approvals. Freyr’s Regulatory services for Iraq span across:

  • Medical Devices
  • Pharmaceuticals (Drugs)
  • Biotech / Biosimilars

Freyr Offerings

  • Strategic Regulatory Consulting
  • Regulatory Affairs & Regulatory intelligence
  • Product registration and renewal
  • Regulatory submissions

Freyr Advantages

  • Strategic and well-versed local regulatory knowledgebase – with the MoH
  • Expert Regulatory team with proven global RA expertise
  • Proactive and collaborative approach
  • Quick turnarounds and faster time-to-market
  • Keeping abreast with region-specific legislation and Regulatory guidelines